Table 5 Correlation analysis of CI outcomes by genetic Subgroup.

From: Analysis of the clinical features of neurocristopathy-related hearing loss and how these relate to outcomes after cochlear implantation

CS Group

    

Variable

CAP_1 year (n = 6)

CAP_3 year (n = 4)

SIR_1 year (n = 6)

SIR_3 year (n = 4)

 

ρ (p)

ρ (p)

ρ (p)

ρ (p)

CI_age_mon

0.41 (0.414)

1.00 (˂0.001)*

0.00 (1.000)

0.95 (0.051)†

gender_male

0.50 (0.313)

0.89 (0.106)

0.25 (0.633)

0.94 (0.057)†

Gesell_mean

0.83 (0.042)*

1.00 (˂0.001)*

0.41 (0.414)

0.95 (0.051)†

abnormal_sum

NaN (NaN)

NaN (NaN)

NaN (NaN)

NaN (NaN)

WS/NS/KS Group

    

Variable

CAP_1 year (n = 10)

CAP_3 year (n = 5)

SIR_1 year (n = 10)

SIR_3 year (n = 5)

 

ρ (p)

ρ (p)

ρ (p)

ρ (p)

CI_age_mon

0.25 (0.495)

0.11 (0.863)

0.77 (0.009)*

0.73 (0.165)

gender_male

0.08 (0.833)

0.15 (0.807)

0.11 (0.758)

0.61 (0.272)

Gesell_mean

0.37 (0.295)

0.58 (0.306)

0.15 (0.680)

0.35 (0.559)

abnormal_sum

0.22 (0.542)

0.35 (0.559)

0.35 (0.327)

−0.79 (0.111)†

  1. Note: Bold: Statistically significant (p < 0.05).
  2. †Marginal significance (0.05 < p < 0.10).
  3. NaN: Not analyzable (all cases had identical abnormality counts).
Back to article page